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CRISPR/Cas9 mediated mutation 
of the mtnr1a melatonin receptor 
gene causes rod photoreceptor 
degeneration in developing 
Xenopus tropicalis
Allan F. Wiechmann1,2*, Teryn A. Martin1 & Marko E. Horb 3
Nighttime surges in melatonin levels activate melatonin receptors, which synchronize cellular 
activities with the natural light/dark cycle. Melatonin receptors are expressed in several cell types in 
the retina, including the photon-sensitive rods and cones. Previous studies suggest that long-term 
photoreceptor survival and retinal health is in part reliant on melatonin orchestration of circadian 
homeostatic activities. This scenario would accordingly envisage that disruption of melatonin receptor 
signaling is detrimental to photoreceptor health. Using in vivo CRISPR/Cas9 genomic editing, we 
discovered that a small deletion mutation of the Mel1a melatonin receptor (mtnr1a) gene causes a loss 
of rod photoreceptors in retinas of developing Xenopus tropicalis heterozygous, but not homozygous 
mutant tadpoles. Cones were relatively spared from degeneration, and the rod loss phenotype was 
not obvious after metamorphosis. Localization of Mel1a receptor protein appeared to be about the 
same in wild type and mutant retinas, suggesting that the mutant protein is expressed at some level 
in mutant retinal cells. The severe impact on early rod photoreceptor viability may signify a previously 
underestimated critical role in circadian influences on long-term retinal health and preservation 
of sight. These data offer evidence that disturbance of homeostatic, circadian signaling, conveyed 
through a mutated melatonin receptor, is incompatible with rod photoreceptor survival.
Circadian (daily) rhythms synchronize to the natural solar cycle via photoreceptive cells in the retina of the eye 
that detect radiant light energy and convey that information to inner retinal cells, some of which project to the 
brain. Cyclic oscillations of intracellular activity occur in many cells of the body, and are especially robust in 
retinal cells since they need to anticipate the 12 magnitudes in ambient light intensity changes that can occur 
over a 24-h  period1. The key circadian signaling molecule of darkness, melatonin, is produced by retinal photo-
receptors at nighttime to drive circadian events in the eye and is secreted into the cerebrospinal fluid and general 
circulation from the pineal  gland2. Melatonin binds to integral membrane G protein-coupled receptors (GPCRs) 
expressed in target cells throughout the body to harmonize cellular activities with the predictable 24-h day/night 
 cycle3. Melatonin receptor subtypes are designated as Mel1a, Mel1b, and Mel1c in amphibians, fish and  birds4, 
and as MT1, MT2, and GPR50 (which does not bind melatonin) in mammals,  respectively3.
One primary function of melatonin in the retina is to enhance visual sensitivity to light at  nighttime5. If the 
solar light cycle is disengaged from circadian cellular readiness, the metabolic imbalance imposed on dark-
adapted photoreceptors by radiant light energy causes cell  damage6. The increased vulnerability of photoreceptors 
to light damage during subjective  night7 is consistent with reports that melatonin receptor activation exacer-
bates light-induced rod cell  death8,9. Together, these studies support the overarching hypothesis that unabated 
activation of melatonin receptors is detrimental to long-term photoreceptor health. Another key role of retinal 
melatonin is to synchronize the daily shedding of photoreceptor outer segment distal tips and their phagocy-
tosis by the adjacent retinal pigment epithelial (RPE)  cells10. The circadian turnover of rod photoreceptor outer 
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segments (ROS) occurs in the early morning in coordination with light  onset11,12, and is essential for long-term 
photoreceptor  health13. An understanding of the molecular mechanisms by which melatonin coordinates cyclic 
ROS shedding and RPE phagocytosis is incomplete.
Historically, Xenopus laevis has been a key animal model in understanding the circadian synthesis and func-
tions of melatonin in the retina. Melatonin is synthesized by Xenopus photoreceptors at  night14–16, due to clock-
regulated synthesizing  enzymes17. Cone photoreceptor inner segments elongate at night and contract during the 
day under the influence of melatonin as a dark-adaptive response in Xenopus18,19. The daily shedding of ROS each 
morning and their subsequent phagocytosis by the RPE is influenced by  melatonin10. In Xenopus retina, dopa-
mine is synthesized by amacrine cells during the daytime, which suppresses melatonin  synthesis20. Conversely, 
melatonin production at night inhibits the release of dopamine from amacrine  cells15,21. Dopamine shifts the 
balance of inputs to horizontal cells from rods to cones, which enhances cone input during the  day21. Melatonin 
is considered to be both an input signal and an output of the circadian clock in Xenopus  photoreceptors22.
Prior to the retinal circadian studies utilizing the Xenopus model, an early study on anuran (Rana pipiens) 
tadpoles provided the first evidence that the pineal gland secretes a compound that causes perinuclear aggrega-
tion of melanosomes in dermal  melanophores23. The discovery by Lerner et al.24 of melatonin extracted of bovine 
pineal gland was facilitated by an in vitro pigment dispersion assay in explant cultures of frog (R. pipiens) skin. 
Further, the early studies by Bagnara and co-workers with X. laevis tadpoles confirmed melatonin as the skin-
blanching signal of the pineal gland in vivo25–27.
We examined the impacts of disrupted melatonin receptor signaling on retinal cell function and viability, 
by mutating mtnr1a receptor gene expression of the Western clawed frog Xenopus (Silurana) tropicalis. We 
used in vivo CRISPR/Cas9  methodologies28 to create F0 founders, and subsequently generated F1 X. tropicalis 
progeny that are heterozygous for the expression of the Mel1a melatonin receptor with a predicted three-amino 
acid (VIL, residues 48–50) in-frame deletion in the first transmembrane domain (Fig. 1). We report here that 
heterozygous mtnr1a VIL deletion mutant tadpoles exhibit pervasive rod photoreceptor dystrophy and/or degen-
eration, whereas cone photoreceptors are relatively more abundant. The F2 homozygous mutant progeny of F1 
mtnr1a VIL heterozygous mutants did not exhibit the same level of rod decline that was observed in retinas of 
their heterozygous mutant siblings. The observation that a small in-frame melatonin receptor mutation causes 
aggressive rod photoreceptor degeneration in heterozygous X. tropicalis supports the concept that circadian 
signaling is necessary for photoreceptor homeostasis and development.
Figure 1.  CRISPR/Cas9 sgRNA targeting of X. tropicalis mtnr1a gene. Upper image: Location of sgRNA 
targets T1, T2, & T3 are indicated by small black bars below the coding sequences (CDS) of exons 2 and 3 (blue 
boxes). The number of nucleotide base pairs (bp) is indicated in the exons and intervening introns. The 5′ and 3′ 
untranslated (UTR) regions are indicated by the red boxes. Lower image: Predicted conformation of X. tropicalis 
Mel1a melatonin receptor on the cell membrane (blue). The sites of the three sgRNA targets are indicated 
by colored residues in the first and fifth transmembrane domains. The receptor diagram (with the N- and 
C-terminal ends omitted for space) was created on the GPCRdb.org website (https ://gpcrd b.org) 74.
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Results
CRISPR sgRNAs direct Cas9 cDNA cleavage in the mtnr1a exon 2 coding region. We created 
mosaic founder mutant (F0 crispant) X. tropicalis animals by microinjecting one-cell embryos with Cas9 protein 
complexed with single-guide (sg) RNAs targeting coding regions in exon 2 (T1 and T2 sgRNA) and/or exon 3 
(T3 sgRNA) of the mtnr1a gene (Fig. 1 and Supplementary Figs. S1-S3). The sgRNAs were injected singly or in 
two different combinations of each other (i.e., T1 & T2, or T1, T2, & T3) with the initial intent of optimizing 
the potential for knockdown of Mel1a receptor expression. The T1 and T2 sgRNAs targeted the proximal and 
distal margins of the first transmembrane domain of the Mel1a receptor protein, respectively, and the T3 sgRNA 
targeted the middle of transmembrane domain 5 (Fig. 1 and Supplementary Figs. S1-S3).
Blitz et al.29 demonstrated that up to two mismatches in the Xenopus sgRNA are tolerated well by the Cas9 
enzyme, resulting in zero off-target mutations (of 619 sites analyzed). We accepted only one or zero mismatches in 
our sgRNA design, which provides greater assurance that our sgRNAs are unlikely to cause undesirable off-target 
effects. Furthermore, a BLAST search of the X. tropicalis genome database (Nigerian version 9.1) on Xenbase 
(https ://www.xenba se.org/entry /) revealed no off-target sites for any of our three sgRNAs used in this study.
sgRNAs targeting Cas9 endonuclease cleavage of the DNA coding region of exons 2 and 3 of the Mel1a 
gene (mtnr1a) were synthesized in vitro and screened for their ability to guide Cas9 protein to the DNA target 
site (Supplementary Fig. S1). Incubation of mtnr1a PCR-amplified DNA templates with Cas9 protein and each 
of three different sgRNAs showed that each sgRNA was effective in directing targeted Cas9 cleavage of DNA 
(Supplementary Fig. S2). The T2 sgRNA, which targets the cytoplasmic end of the transmembrane domain 1 
in exon 2, was more effective (83%) than the T1 sgRNA (69%) and T3 sgRNA (43%) (Supplementary Fig. S2). 
The relative values were consistent with the projected targeting efficiencies analyzed by CHOPCHOP (https ://
chopc hop.cbu.uib.no/). The online tool inDelphi identifies sgRNA sequences with predictable editing outcomes 
(https ://indel phi.giffo rdlab .mit.edu/) 30 to show that the T2 sgRNA in this study is 27% likely to cause a 9-bp 
deletion and 18% likely to cause a 12-bp deletion. We also used CRISPRdirect (https ://crisp r.dbcls .jp/) analysis 
of the 20-mer T2 sgRNA in this study to show that no off-targets occurred in the coding exons elsewhere in the 
X. tropicalis  genome31.
F0 crispant frogs express a variety of indel mutations targeted by the mtnr1a T2 sgRNA. PCR 
products amplified from genomic DNA (gDNA) extracted from tail clips of age- and stage-matched wild type 
(WT) or F0 tadpoles were analyzed by T7 endonuclease I (T7E1) mismatch cleavage  assays32 and direct Sanger 
DNA sequencing. F0 tadpoles were initially screened by T7E1 assays in which mismatched (i.e., heterozygous 
WT and mutant alleles) re-annealed PCR products amplified from gDNA templates are cleaved at the site of 
the mismatch by the T7E1 enzyme, generating two distinct PCR fragments (Supplementary Fig.  S4). Direct 
sequencing of PCR products from F0 mtnr1a mutant gDNA revealed degradation of chromatogram peaks at or 
just downstream of the T2 PAM target site, such as the VIL cleavage site located 4-bp downstream of the PAM 
site (Supplementary Fig. S4). In contrast to the T2 sgRNA, we detected only a few mutants resulting from the T1 
sgRNA, and no mutants from the T3 sgRNA. Thus, mutations of the T1 and T3 regions of the mtnr1a receptor 
gene were not pursued for further study.
Deconvolution of DNA sequences by TIDE analysis (tracking of indels by decomposition; https ://tide.nki.nl) 
33 reveals the difference in aberrant indel sequences between WT and mutant animal sequences. TIDE analysis 
illustrates the range of indel sizes and frequency of expression in four individual F0 founder animals (Supple-
mentary Fig. S5). The T2 sgRNA targeting efficiency varied from 44.6 to 86.2% among the four F0 crispants 
analyzed, and all animals displayed both insertions and deletions near the PAM T2 site. Notably, a 9-bp non-
frameshift deletion was detected in three of the four crispants, which was the size of the prominent deletion 
mutation that we later observed in some F1 heterozygotes, including animals with the 9-bp VIL deletion that 
causes photoreceptor degeneration. WT and VIL homozygote samples showed no significant allelic variance 
compared to the reference trace, as expected.
Genomic DNA was extracted from web clips of five mutant F0 sibling founder frogs raised to sexual maturity. 
The mtnr1a target areas were PCR-amplified and cloned into plasmids for DNA sequencing to identify specific 
indels represented in the mosaic mixture of mutations. Many clones (59 total) displayed mutations in the T2 
target area of exon 2 (Supplementary Fig. S6), which corresponds to the cytoplasmic end of the first transmem-
brane domain of the Mel1a receptor (Fig. 1, Supplementary Figs. S1, S3). Of the 59 mutant sequenced clones, 
there were 23 different indel or substitution mutations identified in the T2 target area (Supplementary Fig. S6).
The VIL deletion mutation of the mtnr1a receptor gene causes rod photoreceptor degenera-
tion in heterozygous tadpoles. When the F0 founders reached sexual maturity, we outcrossed them 
with WT X. tropicalis to assess which mutations were passed into the germline. T7E1 assays performed on 
PCR cDNA amplified from gDNA of F1 animals with different mtnr1a mutations revealed slightly different pat-
terns of mtnr1a cleavage products (Supplementary Fig. S7), consistent with inheritance from mosaic F0 found-
ers. T7E1 assays reliably identified mutant F1 tadpoles from WT, but did not identify the specific mutations 
expressed. Phenotyping and genotyping of F1 tadpoles revealed a correlation of ROS loss with a 9-bp (GGT TAT 
CCT) deletion mutation starting 4-bp downstream of the T2 PAM site at the end of exon 2 of the mtnr1a gene 
(Supplementary Fig. S8). The 9-bp deletion was predicted to cause an in-frame 3-amino acid (valine-isoleucine-
leucine; VIL) deletion. F1 tadpoles were definitively identified as mtnr1a VIL deletion mutants by direct PCR 
sequencing, sequencing of plasmid clones, and restriction fragment length polymorphism (RFLP) analyses. The 
VIL deletion created a unique BseRI endonuclease restriction site (CTC CTC T; Supplementary Fig. S8), ren-
dering it useful for RFLP screening of F1 tadpoles. Incubation of PCR products of gDNA from VIL mtnr1a 
mutants with BseRI endonuclease cleaved the 530-bp PCR product into 189-bp and 341-bp fragments, as pre-
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dicted (Fig. 2a). This RFLP assay positively identified 100% of the F1 heterozygous mtnr1a VIL mutants, as con-
firmed by sequencing of PCR products (Fig. 2b,c) and plasmid clones (Supplementary Fig. S9). DNA sequence 
chromatograms of plasmid clones of F1 mtnr1a VIL mutant animals show no sequence degradation, but instead 
have 9-bp deletions (GGT TAT CCT) beginning at the identical 4-bp downstream site (Fig. 2c,d). The results of 
these analyses confirmed the prediction by  inDelphi30 of a high rate of expression of the 9-bp deletion mutation.
F1 heterozygous progeny of F0 founder mtnr1a CRISPR/Cas9-edited frogs were analyzed morphologically 
at various stages of development by routine H&E histology. Of the over 200 mtnr1a F1 tadpoles or froglets 
examined, obvious and consistent rod degeneration was present in only the 9-bp VIL deletion mutants. The 
absolute number of F1 VIL mutants reported here do not necessarily represent the relative frequency of muta-
tion expression, since our analyses were biased to identify animals with mutations detected by T7E1 assays that 
were then randomly confirmed by sequencing of plasmid clones. Of the 22 mutant animals in which the mtnr1a 
region was cloned and sequenced, 54.5% (12/22) exhibited a VIL deletion (Supplementary Fig. S9). Histologic 
examination of 35-day-old F1 pre-metamorphic VIL mutant tadpoles (stages 50–52) revealed massive loss of 
rod photoreceptors (Fig. 3). The rod degeneration was most pronounced in the central region (near the optic 
nerve head). The severity of photoreceptor degeneration displayed some individual variation, insofar as retinas 
Figure 2.  Identification of heterozygous F1 animals with CRISPR/Cas9 indel mutations of the mtnr1a gene. 
(a) Representative RFLP analysis shows that PCR products of mtnr1a VIL heterozygotes display two predicted 
cleavage bands (arrows), whereas WT and non-VIL mutant DNA is not cleaved. The creation of a BseRI site 
by the VIL deletion is illustrated in Supplementary Fig. S3. (b) Direct PCR Sanger sequencing chromatogram 
of F1 WT progeny display prominent peaks for all bases in the T2 sgRNA target area. The T2 PAM sequence 
(CCT) is boxed in black, and the downstream 9-bp sequence of the mtnr1a VIL deletion mutation is boxed 
in blue. The corresponding amino acid sequence is shown below the nucleotide codon sequence. (c) In an F1 
tadpole heterozygous for the mtnr1a 9-bp (VIL) deletion, the trace decomposes (i.e., mixed base calls) at the 
predicted target site 4-bp downstream of the T2 PAM site, and continues to the end of the trace, as expected for 
a heterozygous indel mutation. The decomposed sequence represents the overlapping peaks of the mtnr1a WT 
and VIL alleles. (d) Partial view of alignments from Poly Peak Parser (https ://yostt ools.genet ics.utah.edu/PolyP 
eakPa rser/) output revealing the heterozygous 9-bp mtnr1a VIL deletion mutation. The WT allele is the top line 
and the mutant allele is the bottom line.
5Vol.:(0123456789)
Scientific RepoRtS |        (2020) 10:13757  | https://doi.org/10.1038/s41598-020-70735-2
www.nature.com/scientificreports/
of some animals were almost devoid of rod cells (Fig. 3a,b,d), whereas others had a substantial number of rods, 
many of which had truncated or otherwise dystrophic outer segments (Fig. 3c).
The number of rod photoreceptors, as determined by number of ROS per mm in the central retina, was 
reduced by 73% (unpaired two-tailed t-test; p = 0.0022) at stages 50–52 (35-day) in mtnr1a VIL mutant tadpoles, 
compared to age- and stage-matched WT siblings (Fig. 3f). In comparison, cone photoreceptors were less affected, 
although the average number of cones per mm declined by 33% (p = 0.0008) in the VIL mutant tadpoles (Fig. 3f). 
The relative difference in means (cells/mm) between WT and mutants was 113.00 ± 22.12 (standard error of the 
mean; SEM) for ROS, and 58.75 ± 7.38 for cones. Notably, cell nuclei of unknown origin were often observed in 
the outer plexiform layer (OPL), which is where photoreceptor terminals contact retinal interneurons, and were 
especially prominent in areas of severe rod loss (Fig. 3a,b,d). There were no obvious morphologic aberrations 
in the RPE in the 35-day heterozygous mtnr1a VIL mutant retinas. We did not detect morphologic deficits in 
retinas of tadpoles at earlier developmental stages (about stages 46–48; 9-and 16-days old).
Tadpoles at stages 54–56 (48-day) displayed central rod dystrophy and degeneration (Fig. 4). Cones were 
abundant and appeared to have normal morphology (Fig. 4a,b). Clusters of shed ROS tips that had not been 
phagocytized by the RPE were often seen in the interphotoreceptor matrix (IPM; Fig. 4a). The presence of large, 
un-phagocytized shed ROS tips in the IPM is abnormal, since ROS shedding and RPE phagocytosis is synchro-
nized to occur at about 2 h after light onset. Serial sections revealed that many of the ROS profiles were indeed 
shed ROS packets rather than obliquely-oriented intact ROS. Tissues of the 48-day tadpoles were fixed at nine 
hours after lights on (i.e., late afternoon), which is well beyond the time where shed large ROS tips are typically 
Figure 3.  Photoreceptors degenerate in stage 50–52 (35-day-old) heterozygous mtnr1a VIL mutant tadpoles. 
(a–d) H&E-stained paraffin sections of the central retina of four different stage 50–52 mtnr1a VIL mutant 
tadpoles display rod loss and/or dystrophy. Retinas of mutant tadpoles have normal appearing cones (white 
arrows), but severely dystrophic rod outer segments (ROS; black arrowheads). Note the frequent absence of rod 
inner segments (asterisks). (b) A presumptive leukocyte is in the area of the interphotoreceptor matrix (IPM) at 
the center of the panel. (c,d) Some ROS persist in the mutant central retinas, but are much shorter than the ROS 
of WT sibling retinas (e), and exhibit some dystrophy. (e) Retinas of WT siblings exhibit healthy rod and cone 
photoreceptors. (f) Quantitative analysis of ROS and cones in WT vs VIL central retinas. The average number of 
ROS (blue bars) or cones (red bars) in 6–12 different retinal sections from four different animals (a–d) in each 
group (i.e., n = 4) were analyzed for statistical significance by an unpaired two-tailed t-test. Error bars indicate 
standard error of the mean (SEM). In mutant retinas, the number of ROS declined by 73% (*; p = 0.0022), 
and cones declined by 33% (**; p = 0.0008) as compared to WT. RPE retinal pigment epithelium, ROS rod 
outer segments, ONL outer nuclear layer, INL inner nuclear layer, IPM interphotoreceptor matrix, cone inner 
segments; white arrows, ROS; black arrowheads, inner segment layer; asterisks. Magnification bars = 20 µm.
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observed in the normal  retina34. Rod degeneration in the stage 54–56 (48-day) F1 pre-metamorphic VIL mutant 
tadpoles was more severe in the central region of the retina than in the dorsal or ventral regions of the peripheral 
retina (Supplementary Fig. S10). The average ROS length in the central retina of mtnr1a VIL mutants decreased 
by 64%, compared to WT siblings. Rod degeneration was consistently less severe in the peripheral regions, with 
the ventral region somewhat less affected than the dorsal region (Supplementary Fig. S10).
Homozygous mtnr1a VIL tadpoles do not exhibit obvious rod degeneration. We raised to adult-
hood a homozygous F1 mtnr1a VIL male frog that resulted from the crossing of two mosaic F0 founders that 
expressed the VIL deletion in their germline (i.e., crispants #1 and #3 in Supplementary Figs. S4-S6). We crossed 
this F1 mutant male to a heterozygous VIL female sibling, which produced an F2 generation with a 50/50 ratio 
of homo-/heterozygous VIL mutant progeny. We also crossed other mature F1 heterozygous VIL mutant siblings 
with each other to generate F2 heterozygous and homozygous progeny. We genotyped these animals with T7E1 
assays in tandem with BseRI RFLP assays and DNA sequencing. Together, these genotyping assays definitively 
identified the F1 and F2 progeny as WT or VIL homozygous or heterozygous mutants (Supplementary Fig. S11).
Phenotype analysis revealed no obvious retinal degeneration in F2 mtnr1a VIL homozygotes (Fig. 5). We 
analyzed F2 mtnr1a VIL mutant heterozygous and homozygous sibling tadpole phenotypes (n = 5) at 4 months 
of age (stage 54–56), which is a somewhat advanced age for this stage of tadpole. In our facility, tadpoles typically 
undergo metamorphosis between 2 and 6 months of age (metamorphosis at about 2 months of age is considered 
optimal in most laboratory settings), possibly due to subtle differences in population density or food intake. 
Thus, animals undergoing metamorphosis ranged in age from 2 to 4 months, which is why all control animals 
in this study were both age- and stage-matched with their mutant counterparts. In these VIL heterozygotes, we 
observed some moderate ROS dystrophy (Fig. 5b), but not as massive as seen at 35 and 48 days (Figs. 3 and 4). 
In contrast, WT siblings (Fig. 5a) and mtnr1a VIL homozygous siblings (Fig. 5c) appeared to have relatively 
normal morphology.
The number of rods and cones appeared to be the same in the WT, VIL heterozygous, and VIL homozygous 
4-month-old tadpole retina sections of tadpoles represented in Fig. 5a–d. However, average ROS length was 
significantly lower (24%) in VIL heterozygous animals compared to WT, as measured by an unpaired two-
tailed t-test (p = 0.0267). The ROS length of VIL homozygous animals were on average 15% lower than WT, but 
were not statistically different from WT siblings (p = 0.0867). These data provide quantitative support that VIL 
heterozygotes exhibit a moderately more severe degenerative phenotype than do the VIL homozygous mutant 
tadpoles examined in this study. Because of the inherent individual and developmental variation of phenotype 
severity, further analysis of additional animals could enable more detailed analyses of the mutant phenotypes.
Figure 4.  Rod photoreceptors are dystrophic in stage 54–56 (48-day-old) heterozygous mtnr1a VIL mutant 
tadpoles. (a,b) H&E-stained paraffin sections of central retina from a 48-day VIL mutant tadpole displays ROS 
dystrophy (black arrowheads), whereas cones appeared relatively normal (white arrows). Single or clusters 
of large shed ROS (asterisks) were often present in the interphotoreceptor matrix. (c) Retinas of WT siblings 
exhibit healthy-appearing rod and cone photoreceptors. RPE retinal pigment epithelium, ROS rod outer 
segments, ONL outer nuclear layer, INL inner nuclear layer, cone inner segments; white arrows, ROS; black 
arrowheads, shed ROS tips; asterisks. Magnification bars = 20 µm.
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Mel1a receptor proteins are expressed at WT levels in VIL heterozygote and homozygote reti-
nas. Immunohistochemistry (IHC) was used to determine if VIL mutant Mel1a receptor proteins of VIL 
heterozygous and homozygous animals are expressed at comparable levels as WT receptor proteins in the ret-
ina and other tissues. The specificities of the antibodies to X. laevis melatonin receptors have been previously 
 reported35–38. Retinas of tadpoles in all three genotype groups displayed about the same intensity and localization 
of expression of the Mel1a receptor protein (Fig. 6a–f). It is important to note that since immunofluorescence 
is not considered to be a quantitative measure, no attempt was made to quantify differences in immunolabeling 
intensities. Particularly, Mel1a receptor immunoreactivity was prevalent on or near the plasma membrane of the 
photoreceptors, suggesting that some of the receptor is trafficked to the cell surface. Mel1a immunoreactivity 
was especially robust in cone inner segments in all animals tested. Retina sections incubated without primary 
antibody displayed no specific immunoreactivity (Fig. 6g,h).
Post-metamorphic heterozygous mtnr1a VIL deletion mutant adult frogs display abundant 
rod photoreceptors. In contrast to the obvious rod degeneration observed in mutant tadpoles, young 
adult post-metamorphic (stage 66; 12-month) mtnr1a VIL heterozygous mutant frogs displayed abundant 
ROS, although their density was slightly lower (about 15%) in mutant retinas compared to those of WT siblings 
(Fig. 7a,b). Only two young adult VIL homozygous frogs were available for morphologic analysis, since all other 
homozygous animals were used for the earlier developmental analyses. In these two animals, we did observe 
significant ROS dystrophy, but the n = 2 limits our confidence in these observations, which need to be addressed 
further when the next generation of tadpoles are raised to sexual maturity.
Large frameshift deletion mutation of the mtnr1a receptor does not result in rod degenera-
tion. To examine the potential for mtnr1a knockout mutations, we analyzed F1 heterozygous tadpoles that 
express a 56-bp deletion mutation predicted to knock down Mel1a protein expression. The 56-bp deletion 
includes the exon 2/intron 2 splice site, so deletion of the splice site may potentially allow translation to con-
tinue into the intron (Supplementary Fig. S12). No premature stop codons appeared in the 270-bp of readable 
sequence downstream from the end of the deletion. The potential that such an aberrant protein sequence would 
be translated in the mutant cells is improbable, because the mRNA would potentially enter the nonsense-medi-
ated decay pathway and/or the mutant receptor protein would likely be degraded and thus not trafficked to the 
cell surface. It is therefore likely that this mutation causes knockdown of receptor expression and/or traffick-
ing, but it requires further study. We did not observe any obvious deleterious impacts on rod survival in these 
Figure 5.  Rods are dystrophic in stage 54–56 (4-month-old) F2 heterozygous but not homozygous mtnr1a 
VIL mutant tadpoles (n = 5). F2 heterozygous and homozygous tadpoles were generated by crossing two F1 VIL 
mutant heterozygotes. (a) WT siblings of F2 mutants exhibit healthy-appearing rod and cone photoreceptors. 
(b) Central retinas of VIL mutant heterozygous tadpoles display ROS dystrophy and abnormal distribution 
of RPE cells, whereas cones appear relatively normal (white arrows). (c) Retinas of homozygous VIL mutant 
siblings display morphologies similar to WT siblings. (d) Quantitative measurements of rod dystrophy in 
X. tropicalis retinas show that rod outer segment (ROS) length is diminished significantly by 24% in VIL 
heterozygous 4-month-old tadpoles, compared to WT when analyzed by an unpaired two-tailed t-test (*; 
p = 0.0267, n = 3). The 15% decline in ROS length in VIL homozygous tadpoles compared to WT was statistically 
insignificant (p = 0.0867, n = 3). No significant differences in rod (i.e., ROS) or cone abundance were observed 
among the three genotype groups. Measurements were made of digital images of groups of 4-month-old 
tadpoles represented in a–c. Error bars indicate standard error of the mean. RPE retinal pigment epithelium, 
ROS rod outer segments, ONL outer nuclear layer, INL inner nuclear layer, cone inner segments; white arrows. 
Magnification bars = 20 µm.
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animals (Fig. 8c,d), and we thus tentatively suggest that tadpoles that are heterozygous for the mtnr1a 56-bp 
deletion mutation do not display the severe degenerative phenotype as seen in the heterozygous VIL deletion 
tadpoles.
Figure 6.  Retinas of heterozygous and homozygous mtnr1a VIL mutant tadpoles display Mel1a protein 
expression at intensities similar to WT siblings. Double-label confocal immunohistochemistry (IHC) of (a,b) 
WT, (c,d) F2 VIL heterozygous, and (e,f) F2 VIL homozygous tadpole head paraffin sections was performed 
with antibodies to X. laevis Mel1a (red label) and Mel1b (green label) melatonin receptors. Panels on the right 
are higher magnifications of areas in panels on the left side of the figure. Mel1a receptor fluorescent signal 
intensity and location appears to be similar in animals of all three genotypes. The Mel1a receptor is expressed in 
RPE, rod and cone photoreceptors (arrows), and inner retinal neurons. The Mel1a and Mel1b receptors display 
an expression pattern different from each other, although there are areas in which the red and green labels 
merge as a yellow label, suggestive of co-expression and/or very close proximity to each other. (g,h) WT retina 
sections processed for IHC with Mel1b antibodies, but without Mel1a antibodies (No 1° red) display specific 
immunofluorescence for Mel1b (green), but not for Mel1a (red). RPE retinal pigment epithelium, ROS rod outer 
segments, ONL outer nuclear layer, INL inner nuclear layer, IPL inner plexiform layer, arrows; rod photoreceptor 
inner segments. Magnification bars = 20 µm.
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Figure 7.  Heterozygous mtnr1a VIL mutant young adult (juvenile) frogs display normal rods and cones. (a) 
WT juvenile frogs display normal rods (ROS) and cones. (b) F1 mtnr1a VIL heterozygous mutant juvenile 
sibling frogs display healthy-looking rods and cones, although the ROS density appears to be lower than in 
WT (asterisks). Mtnr1a 56-bp deletion mutant tadpoles do not display rod dystrophy. (c) Four-month-old WT 
tadpole retinas and (d) F1 mtnr1a heterozygous 56-bp deletion (potential knockout) siblings exhibit healthy-
appearing rods (ROS) and cones (white arrows). RPE retinal pigment epithelium, ROS rod outer segments, ONL 
outer nuclear layer, INL inner nuclear layer. Magnification bars = 20 µm.
Species Receptor Transmembrane domain 1 Intracellular loop 1
H. sapiens MT1 G N L L V I L S V Y R - N K K L R N A
X. tropicalis Mel1a G N L L V I L S V F R - N R K L R N A
H. sapiens MT2 G S L L V  I I S  V L K - N R K L R N S
X. tropicalis Mel1b G N L I V I L S V L R - N R K L R N S
Relative percent expression of residues at the human and X. tropicalis Mel1a and Mel1b receptors:
Yellow: 100% Grey: 75% Underline: 50% Bold: 25% Hyphen (-): TM1-ICL1 junction
Human MT1: I49N polymorphism in Autism Spectrum Disorders [59]
Human MT2: L60R polymorphism in Type 2 Diabetes [57]
Figure 8.  Amino acid alignment of the endofacial portion of the first transmembrane domain of human and 
X. tropicalis melatonin receptors. The hydrophobic residues of transmembrane domain 1 (TM-1) located near 
the membrane cytoplasmic surface is highly conserved among GPCRs, as exemplified by the alignment of this 
region in the human MT1 and MT2 receptors and the homologous X. tropicalis Mel1a and Mel1b receptors. The 
human MT1 and Xenopus Mel1a receptors show a 100% amino acid identity in the GNLLVILSV 9-bp region in 
TM-1. The first intracellular loop (ICL-1) is also highly conserved, as indicated in yellow. The mtnr1a T2 sgRNA 
most effectively targeted the hydrophobic LLVIL residues (see Supplementary Fig. S6) in the center of the 
Xenopus Mel1a endofacial TM-1 region illustrated here. This region is the site of a human MT1 nonsynonymous 
point mutation (I49N) associated with  autism59 and a human MT2 mutation (L60R) linked to type 2  diabetes57. 
The amino acid point mutations associated with each disorder are indicated by a blue box.
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Discussion
To examine the role of melatonin receptor signaling on retinal circadian functions, we mutated the mtnr1a mela-
tonin receptor gene of X. tropicalis using CRISPR/Cas9 and generated heterozygous F1 progeny, and analyzed 
their retinal morphology. Unexpectedly, we observed a massive loss of rod photoreceptors in F1 heterozygous 
mutant tadpoles with a 9-bp deletion near the end of exon 2 of the Mel1a receptor (Figs. 3,4). This mutation is 
predicted to create a three amino acid (valine-isoleucine-leucine; VIL) non-frameshift deletion near the cytosolic 
end of the first transmembrane (TM-1) domain of the Mel1a receptor protein (Supplementary Figs. S1, S3). 
This phenotype was surprising, since earlier studies using MT1 and MT2 knockout mice revealed rather subtle 
temporal shifts in some circadian functions of the  retina39,40 and a moderate reduction in cone viability in aged 
knockout  mice41. We observed rod degeneration in mtnr1a VIL heterozygous mutant tadpoles as early as day 
35 post-hatching (about stages 50–52). There was some individual variation in severity of rod degeneration at 
all stages examined (Fig. 4), which is typical of inherited heterozygous  mutations42,43. Until the phenotype of 
homozygous adult frogs is further documented, we suggest cautious interpretation of the potential events that 
cause the dystrophic changes that occur in rods of developing tadpoles.
Dimerization of the Mel1a VIL mutant with WT Mel1a, 1b, or 1c receptor protomers in the endoplasmic 
reticulum (ER) may divert the VIL/WT dimer into the proteasome degradative pathway, causing a dominant 
loss-of-function. Additionally, retention of mutant melatonin receptors in the ER may be detrimental to pho-
toreceptor health due to ER  stress44–47. Also, VIL/WT dimers may impede normal WT homodimer signaling 
by forming complexes that are uncoupled from the internalization and sequestration pathways that are crucial 
for normal down-regulation of receptors. This could keep them active during periods of chronic exposure to 
radiant light energy, which could cause a loss-of-function of the WT receptor subtypes. We observed that Mel1a 
immunoreactivity is present on or near the cell surface of photoreceptors and other retinal cells of WT and VIL 
mutants (Fig. 6). Thus, some Mel1a VIL/WT dimers could feasibly be trafficked to the plasma membrane and 
assume an aberrant role in melatonin signaling.
In a rod gain-of-function model, constitutive activation (i.e., during both night and day) of the receptor 
could increase susceptibility of the rods to light-induced photoreceptor degeneration. This hypothesis is sup-
ported by evidence that treatment with melatonin during periods of light exposure is detrimental to long-term 
rod photoreceptor  viability8. Dimerization of GPCR monomers (including MT1/MT2) is widely-considered to 
be essential to receptor  functions48. Fukami et al.48,49 have proposed a paradoxical gain-of-function mechanism 
in which most WT GPCRs reside on the cell surface as homodimers or heterodimers under basal conditions, 
and that the presence of mutant/WT receptor dimers on the cell surface can negatively affect the activity and/
or cellular regulation of the WT dimer partners. The authors described a ‘paradoxical’ gain-of-function of the 
GPCR prokineticin receptor 2 (PROKR2)49. In this example, PROKR2 mutation in a girl with precocious puberty 
enhanced signal transduction in vitro when co-expressed with the WT receptor, compared to expression of the 
mutant (i.e., homozygous ) or WT receptors alone. PROKR2 is known to exist as a dimer in vivo50.
One of the earliest reports of an activating mutation in the TM-1 helical domain was of the lutropin  receptor51. 
The TM-1 domain is also the general location of the Mel1a receptor VIL deletion in Xenopus in the current 
report. An alanine to valine substitution in TM-1 identified in a heterozygous lutropin receptor mutant human 
patient causes a 7.5-fold increase in cyclic AMP synthesis in vitro51. The authors suggest that structural changes 
induced by this mutation are likely to create significant conformational modifications, such as retaining the 
receptor in an activated state. Another pertinent example to support the precedent for GPCR dimerization via a 
TM-1 interface is the thromboxane  A2 prostanoid receptor (TP)52. Dimerization (i.e., FRET signal) and conse-
quent increased signaling was evident in cell cultures co-expressing the two WT monomers. However, receptor 
dimerization did not occur in cells expressing only a TM-1 mutant pair (representative of a homozygous mutant 
genotype), or a WT and TM-1 substitution mutant TP monomer (i.e., heterozygous equivalent). This study 
provided evidence that hydrophobic residues of GPCR TM-1 domains may be necessary for dimer formation 
of some GPCRs. Further, ligand-promoted internalization of WT TP receptor occurred only when both α and β 
isoforms (which form heterodimers in vivo) were co-expressed52. Another study has shown that ligand-induced 
inositol phosphate signaling is enhanced in vitro in cells that co-express both α and β monomers, compared to 
either protomer individually53.
In an RPE or rod loss-of-function model, the mutant Mel1a receptor protein dimerizes with WT Mel1a recep-
tor in the ER, which could divert both receptors into the proteasome degradative pathway rather than to the cell 
surface. This would severely reduce WT receptor expression at the cell surface, which is a well-known mechanism 
by which GPCR mutations exert dominant negative  phenotypes49. In support of this scenario, loss of circadian 
Mel1a receptor signaling impairs the ability of mouse RPE cells to phagocytize shed rod outer segments at the 
appropriate circadian  time39. Furthermore, deficits in circadian RPE functions potentially lead to photoreceptor 
degeneration in many species, including  humans54,55. Rod degeneration, due to retention of mutant receptors in 
the ER, is also a common scenario in several blinding disorders of  humans44,45,47.
Since many organ systems throughout the body express melatonin receptors, one scenario is that aberrant 
Mel1a receptor function in other affected target organs could potentially contribute systemically to the degenera-
tive phenotype observed in the mtnr1a VIL retina. The high metabolic activity of photoreceptors makes them 
particularly vulnerable to metabolic  disorders56, so they may manifest degenerative responses earlier than cells 
in other organ systems. Therefore, the concept that systemic disturbances in melatonin signaling might also 
contribute to the retinal phenotype should be considered and tested.
The region of the X. tropicalis Mel1a receptor that was most effectively targeted for CRISPR/Cas9 mutagenesis 
in this study was the cytoplasmic end of TM-1 (Fig. 1, Supplementary Figure S1). There is a high degree of amino 
acid homology in this hydrophobic region among the human MT1 and MT2 receptors and the X. tropicalis Mel1a 
and Mel1b receptors (Fig. 8). A nine-amino acid sequence (GNLLVILSV) in this region displays 100% identity 
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between the human MT1 and X. tropicalis Mel1a receptors, and these same regions of the human MT2 and X. 
tropicalis Mel1b receptors display 89% (8/9) amino acid identity. Similarly, the first intracellular loops (ICL-1) 
show high degrees of homology between species and receptor subtypes (Fig. 8). The high homology of the human 
MT1 and X. tropicalis Mel1a receptors in this characteristically conserved region favors the functional relevance 
of mutational studies of the frog Mel1a receptor to human health.
In the RPE of X. laevis, Mel1a and Mel1c immunoreactivity is located on the apical microvilli, whereas Mel1b 
is localized primarily to the basolateral portion of the RPE membrane and  cytoplasm38. This same pattern of 
melatonin receptor subtypes occurs in the X. tropicalis RPE (Fig. 6). Mel1a is localized to rod and cone photo-
receptor inner segment plasma membrane and cytoplasm (Fig. 6), similar to the pattern seen in X. laevis. In X. 
laevis inner retina, Mel1a receptors are reported to be expressed in horizontal, amacrine, bipolar, and ganglion 
 cells35–38. The pattern of Mel1a immunoreactivity in the X. tropicalis inner retina appears very similar to that 
reported earlier for X. laevis, but will require more in-depth analyses. The presence of Mel1a immunoreactivity 
in the retina of homozygous VIL mutants supports the concept that at least some of the mutant Mel1a protein 
is synthesized by retinal cells and trafficked to the cell surface.
A cluster of single-nucleotide polymorphisms (SNPs) of hydrophobic residues in TM-1 (i.e., P36S, A42P, 
A52T, and L60R) of the human MT2 receptor is reported to be associated with type 2 diabetes (T2D)57,58. The 
L60R variant of the human MT2 receptor is located in the same highly conserved hydrophobic region of TM-1 as 
the X. tropicalis mtnr1a mutations described in the current study (Fig. 8). Moreover, genetic screening of a large 
European cohort revealed that in one autistic child, a heterozygous MT1 nonsynonymous point mutation (I49N) 
variant causes severe disruption of receptor binding, signaling and trafficking in vitro59. The mutation occurs 
in the same highly conserved region of the endofacial portion (i.e., the cytoplasmic end of the TM-1 domain) 
as is the targeted T2 sgRNA X. tropicalis mtnr1a VIL mutation reported here (Fig. 8). Hydrophobic residues on 
GPCR transmembrane domains, especially TM-1, TM-2, TM-4, and TM-5 are candidates that interface with 
each other as dimers and/or higher-order oligomeric  clusters60–66. It is widely recognized that oligomerization of 
GPCRs often influence ligand binding, G protein coupling, intracellular signaling, and receptor  trafficking67,68.
Global knockout of MT1 in mice appears to have substantive, yet relatively mild effects on 
 metabolism3,39,40,69–71. These observations in knockout mice contrast with the severe rod degeneration phenotype 
that we report here for the X. tropicalis mtnr1a receptor in-frame deletion mutants. These differences make a case 
for the value of detailed phenotypic analyses of different mutations in the transmembrane domains of melatonin 
receptors. Such comparisons may lead to greater understanding of the molecular mechanisms by which melatonin 
receptor signaling contributes to tissue homeostasis. Production of F1 and F2 generations of heterozygous and 
homozygous mtnr1a mutant progeny derived from the F0 founders described here may thus provide unique 
avenues to gain further insights into molecular mechanisms by which melatonin receptor signaling influences 
tissue development and homeostasis.
Our observation that a 56-bp deletion mutation (potential knockout; Fig. 7) does not recapitulate the VIL het-
erozygous mutation (Figs. 3, 4) may guide future efforts to reconcile the dramatic phenotype variances between 
the X. tropicalis mtnr1a VIL non-frameshift deletion and the established mouse MT1 knockout models. The Xeno-
pus and mouse models of melatonin receptor disruption therefore have the potential to reinforce and complement 
one another and to further their applicability to human retinal degenerations. Together, they may provide novel 
insights on the influence of melatonin receptor circadian signaling in maintaining photoreceptor viability within 
the context of modern societies that are increasingly untethered from their natural circadian cycles.
Materials and methods
sgRNA design and preparation. Three sgRNAs with one or fewer mismatches targeting the mtnr1a cod-
ing regions were designed using CHOPCHOP (https ://chopc hop.cbu.uib.no/) and/or CRISPRScan (https ://www.
crisp rscan .org) 72. We checked for target specificity by a BLAST search of potential sgRNA targets using GGGe-
nome (https ://gggen ome.dbcls .jp/). We used the online tool inDelphi, which identifies sgRNA sequences with 
predictable editing outcomes (https ://indel phi.giffo rdlab .mit.edu/) 30 to show that the T2 sgRNA in this study is 
27% likely to cause a 9-bp deletion and 18% likely to cause a 12-bp deletion. We also used CRISPRdirect (https ://
crisp r.dbcls .jp/) analysis of the 20-mer T2 sgRNA in this study to show that no off-targets occurred in the coding 
exons elsewhere in the X. tropicalis  genome31. The sgRNAs used in this study were designated as T1, T2, and T3, 
based on their relative positions downstream of the 5′ start codon. The mtnr1a protein (Mel1a) transmembrane 
domains were determined and plotted using Protter (https ://wlab.ethz.ch/prott er) 73 and GPCRdb (https ://gpcrd 
b.org) 74. The nucleotide (nt) sequences used to generate PCR templates for sgRNA synthesis were designed with 
the protospacer adjacent motif (PAM) site removed and the two nucleotides at the 5′ end of the 20-nt target 
sequence were altered to GG when necessary in the oligonucleotide forward primer (Supplemental Fig. S1) 75. 
Standard desalted sgRNA forward 60-nt and the 80-nt universal Cas9 reverse oligonucleotide  primers75 (Sup-
plemental Fig. S1) were custom-synthesized (Sigma). To generate DNA templates for sgRNA synthesis, we used 
a PCR-based strategy to make linear double-stranded DNA templates for in vitro  transcription76. The two long, 
partially overlapping, forward and reverse oligonucleotides were annealed and used as PCR primers with a high 
fidelity Q5 DNA polymerase (New England BioLabs [NEB]; Supplemental Fig. S13). PCR products were puri-
fied using QIAquick (Qiagen) columns, and approximately 300 ng of DNA was used as a template for the SP6 
in vitro transcription reaction, using MEGAscript™ SP6 in vitro transcription kits according to manufacturer 
instructions (Ambion).
Xenopus tropicalis maintenance and embryo microinjections. The mtnr1a X. tropicalis F0 found-
ers in this study were generated at the National Xenopus Resource (NXR) of the Marine Biological Labora-
tory (MBL). They were transported as 2-week old tadpoles to our satellite aquatics facility at the University of 
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Oklahoma Health Sciences Center (OUHSC). They were maintained in accordance with the established animal 
housing and procedure protocols at the  NXR77,78, which were approved by the Institutional Animal Care and 
Use Committees at OUHSC and MBL. Sexually mature adult male and female Nigerian strain X. tropicalis were 
purchased from the NXR (RRID:SCR_013731, https ://www.mbl.edu/xenop us), and housed at the OUHSC facil-
ity adhering to the protocols described by McNamara et al.77. Embryos were generated according the procedures 
described by Wlizla et al.78,79. One-cell stage embryos were microinjected with 5 nl containing 500 ng of Cas9 
protein complexed with 750 pg of both the T1 and T2 sgRNAs, with 0.1% Texas Red dextran. Developing tad-
poles were staged according to the X. laevis normal table of Nieuwkoop and  Faber80.
Tadpole siblings that were generated from either sgRNA/Cas9 microinjections or natural matings were raised 
in identical housing conditions to minimize individual or various environmental influences. Tadpoles were 
initially maintained in 4-L tanks in an environmental incubator at 27 °C until they were at least 2 weeks old, and 
then transferred to larger tanks as necessary. They were reared on a 12/12 h light/dark cycle, with an average 
daytime light exposure of about 900 lx. While in the environmental incubator, animal tanks were rotated daily 
at feeding time to account for potential differences in their location relative to the lighting source. When they 
were transferred to larger housing tanks, we continued to monitor the temperature, lighting regime, distance 
from light source, and water quality for consistency among tanks. All tadpoles were housed at the identical light 
intensity and duration, tank density, feeding amounts and schedule, and water changes. As much as possible, we 
used siblings raised together in the same tanks for any particular phenotype analysis.
gDNA extraction and genotyping assays. Tissues were obtained from tail clips of anesthetized or 
euthanized tadpoles over four weeks of age and web clips of anesthetized adult frogs, or from euthanized tad-
poles less than 15 days old. gDNA was extracted using a Wizard® Genomic DNA Purification Kit (Promega) 
according to manufacturer’s instructions. gDNA (100–200 ng) from F0 and F1 animals was used as the template 
in 50 µl PCR reactions with EmeraldAmp® GT PCR Master Mix (Takara) (Supplementary Fig. S13). For T7E1 
assays, PCR products were denatured at 95 °C for 3 min and slowly re-annealed to 4 °C at a rate of − 0.01 °C/s. 
Re-annealed PCR samples were digested with T7E1 (NEB) for 1 h at 37 °C, and then for 2 min at 70 °C to inacti-
vate the enzyme. For RFLP assays, 200–300 ng of mtnr1a PCR product was incubated overnight at 37 °C with 1.5 
units of the restriction enzyme BseRI (NEB) in NEB 1 × CutSmart® buffer. For direct Sanger sequencing of PCR 
products, PCR cDNA bands were excised from the gel and purified with EconoSpin® Mini Spin Columns (Epoch 
Life Science) and the DNA was sequenced with an ABI 3,730 capillary sequencer by the core DNA Sequencing 
Facility at the Oklahoma Medical Research Foundation (OMRF; Oklahoma City, OK). Sequences were analyzed 
by trace decomposition (https ://tide.nki.nl) to reveal the spectrum of indel sizes and  frequencies81, and by Poly 
Peak Parser (https ://yostt ools.genet ics.utah.edu/PolyP eakPa rser/) to identify indel  mutations82. To clone PCR 
products for sequencing, PCR products were inserted into pCR™ 4-TOPO (Invitrogen) cloning vectors in One-
Shot® TOP10 competent cells according to the manufacturer’s instructions. Plasmid mini-preps from single 
colonies were sequenced at OMRF using the standard M13 Forward and Reverse primers.
Histologic analysis and immunohistochemistry (IHC). Euthanized tadpoles were immersion fixed 
in 4% paraformaldehyde in PBS for paraffin processing and H&E staining. Double-label IHC was performed 
on paraffin sections with affinity-purified chicken anti-X. laevis  Mel1a35–38 and rabbit anti-Mel1b  antibodies35,38. 
The immunizing peptide for production of the chicken anti-Mel1a receptor was KPDNKPKLKPHDFR, corre-
sponding to the middle region of the third intracellular loop, which is located between TM-5 and TM-6 (Sup-
plementary Fig. S3). Sections were incubated in blocking buffer (2% BSA, 0.2% Triton-X in PBS) and then incu-
bated in the same buffer with 10 μg/ml polyclonal melatonin receptor antibodies overnight at RT. For negative 
controls, sections were incubated in blocking buffer lacking the primary antibodies or by pre-incubating the pri-
mary antibody with an approximate 20-fold molar excess of the immunizing peptide (100 μM). After rinsing in 
PBS, sections were incubated in combinations of 2 μg/ml of goat anti-rabbit antibody conjugated to AlexaFluor 
488 and goat anti-chicken conjugated to AlexaFluor 568 (Molecular Probes). Sections were cover-slipped with 
ProLong™ Gold antifade reagent with DAPI (Invitrogen). Specimens were viewed by confocal microscopy, using 
an Olympus FluoView 1,000 laser-scanning confocal microscope. Quantitative measurements of the number of 
rods and cones per mm of retina were performed with NIS Elements (Nikon) software. Differences in experi-
mental groups were assessed by unpaired two-tailed t-tests using GraphPad Prism® to calculate the standard 
error of the mean and statistical significance between the groups that were analyzed.
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